# Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma

> **NCT04747145** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Medical College of Wisconsin** · enrollment: 38 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **DEVICE:** Radiation
- **DRUG:** Concurrent Chemotherapy (Temozolomide)
- **DRUG:** Adjuvant Chemotherapy (Temozolomide)

## Key facts

- **NCT ID:** NCT04747145
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-06-03
- **Primary completion:** 2025-03-05
- **Final completion:** 2027-09
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2025-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04747145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04747145, "Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04747145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*